Akèy › Kansè Poumon ki pa ti selil › Illinois › Champaign
Etid klinik pou Kansè Poumon ki pa ti selil nan Champaign, IL
11 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Champaign (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Carle Cancer Center, Urbana · 2 mi lwen
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Ap rekriteFaz 3
- Carle Cancer Center, Urbana · 2 mi lwen
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Ap rekriteFaz 3
- Local Institution - 0423, Urbana · 2 mi lwen
Pan-tumor MRD Study
Ap rekriteEtid obsèvasyon
- Carle Health, Urbana · 2 mi lwen
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Carle Cancer Center, Urbana · 2 mi lwen
- The Carle Foundation Hospital, Urbana · 2 mi lwen
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Ap rekriteFaz 1/2
- Carle Cancer Institute, Urbana · 2 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Carle Cancer Center, Urbana · 2 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Carle Cancer Center, Urbana · 2 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Carle Cancer Center, Urbana · 2 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Carle Cancer Center, Urbana · 2 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Carle Cancer Center, Urbana · 2 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Champaign
- Kansè nan tete11 etid
- Kansè poumon9 etid
- Kansè pwostat8 etid
- Kansè Endomèt6 etid
- Kansè (tout kalite)6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Melanom6 etid
- Kansè kolorektal6 etid
- Kansè larinks5 etid
- Kansè bouch5 etid
- Kansè renn (Kasinom selil renn)5 etid
- Kansè pankreyas5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.